NIH-funded research NIH-funded research

Cerebellar Deep Brain Stimulation for Spinocerebellar Ataxias

Official title: Human Cerebellar Deep Brain Stimulation and Recordings in Spinocerebellar Ataxias

Funded at Columbia University Health Sciences · NIH-11602642 · Data updated 2026-11-12

A preliminary clinical trial will test delivering electrical stimulation to the cerebellum in people with spinocerebellar ataxia to see if it improves balance and coordination.

More Deep Brain Stimulation research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 9, 2025
Project endAugust 31, 2030
Funding year2026
Award (this year)$1,900,375
NIH project number4UH3NS140720-02
Project IDNIH-11602642 on NIH RePORTER

Who could benefit from this research

Could help

Adults with spinocerebellar ataxia eligible for neuromodulation and who meet trial-specific safety criteria.

Less likely to help

Some participants may not experience improvement or could have procedure-related risks.

What this research studies

This funded project aims to test whether deep brain stimulation of the deep cerebellar nuclei can reduce ataxia symptoms in people with SCA. Researchers will conduct a Phase 1 study in the United States to evaluate safety and potential signals of effectiveness, building on encouraging animal studies and a few early human cases. The team at Columbia University will use careful monitoring and standardized movement assessments to understand how cerebellar DBS affects the circuit that controls movement in different SCA types. If initial results are promising, they will inform the design of larger trials to determine broader benefit.

Why it matters

Potential benefit: If successful, this approach could provide a new treatment option that improves balance and motor control for people with SCA.

How similar studies have gone: Preliminary case series in Brazil suggested symptom improvements, supporting progression to a rigorous US Phase 1 trial.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Kuo, Sheng-Han — Columbia University Health Sciences
  • Study coordinator: Kuo, Sheng-Han

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.